SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
HUMA

Humacyte, Inc. (NASDAQ:HUMA)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.40-0.03 (-7.99%)
 
Market cap
$111M
Insider Score
Analyst consensus
Listed since
Dec 1, 2020
Insider Score
/ 100
HUMA Insider Score

Humacyte, Inc. has a live Insider Score.

Scored on 3 qualifying trades from 1 insider in the last 90 days.

Unlock the score

HUMA analyst forecast

HUMA analyst consensus

Moderate Buy2 ratings
Buy 2 Hold 0 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

HUMA 12-month price target

$2.50+524.1% upsideaverage of 2 firms
$3.00High
$2.00Low

Best analysts covering HUMA

  • Benchmark20%success rate · 15 calls
  • D. Boral Capital0%success rate · 20 calls
  • HC Wainwright & Co.0%success rate · 6 calls
  • BTIG0%success rate · 4 calls

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

HUMA analyst ratings

FirmPrice targetAction
—BenchmarkSpeculative Buy——Reiterated2026-08-13
BTIG—$2.00+213.6%—2026-08-12
—BTIGBuy——Reiterated2026-07-28
—TD CowenBuy——Reiterated2026-06-17
—BTIGBuy——Reiterated2026-06-16
—HC Wainwright & Co.Buy——Reiterated2026-06-11
—BTIGBuy——Reiterated2026-06-08
—BenchmarkSpeculative Buy——Reiterated2026-06-01
—HC Wainwright & Co.Buy——Reiterated2026-05-26
—TD CowenBuy——Reiterated2026-05-14
—BTIGBuy——Reiterated2026-05-13
—BTIGBuy——Reiterated2026-04-28
—D. Boral CapitalBuy——Reiterated2026-04-28
—D. Boral CapitalBuy——Reiterated2026-04-24
—D. Boral CapitalBuy——Reiterated2026-04-21
—BarclaysOverweight——Reiterated2026-04-08
—BenchmarkSpeculative Buy——Reiterated2026-03-31
—Piper SandlerNeutral——Reiterated2026-03-30
—TD CowenBuy——Reiterated2026-03-30
—D. Boral CapitalBuy——Reiterated2026-03-27
—BTIGBuy——Reiterated2026-03-27
—D. Boral CapitalBuy——Reiterated2026-03-19
—D. Boral CapitalBuy——Reiterated2026-03-17
—D. Boral CapitalBuy——Reiterated2026-02-19
—D. Boral CapitalBuy——Reiterated2026-02-09
—BTIGBuy——Reiterated2026-02-09
—BenchmarkBuy——Reiterated2026-01-21
—D. Boral CapitalBuy——Reiterated2026-01-08
—D. Boral CapitalBuy——Reiterated2026-01-05
—D. Boral CapitalBuy——Reiterated2025-12-22
H.C. Wainwright—$3.00+122.2%—2025-12-01
—BTIGBuy——Reiterated2025-11-21
—D. Boral CapitalBuy——Reiterated2025-11-20
—BenchmarkBuy——Reiterated2025-11-13
—D. Boral CapitalBuy——Reiterated2025-11-13
—D. Boral CapitalBuy——Reiterated2025-11-12
—D. Boral CapitalBuy——Reiterated2025-11-10
—BTIGBuy——Reiterated2025-10-13
—D. Boral CapitalBuy——Reiterated2025-10-06
—D. Boral CapitalBuy——Reiterated2025-09-30
—D. Boral CapitalBuy——Reiterated2025-09-18
—D. Boral CapitalBuy——Reiterated2025-09-15
Barclays—$3.50+138.1%—2025-08-27
—TD CowenBuy——Reiterated2025-08-12
—HC Wainwright & Co.Buy——Reiterated2025-08-12
—D. Boral CapitalBuy——Reiterated2025-08-11
—D. Boral CapitalBuy——Reiterated2025-07-23
—D. Boral CapitalBuy——Reiterated2025-07-09
—D. Boral CapitalBuy——Reiterated2025-06-09
—BenchmarkBuy——Reiterated2025-05-14
—D. Boral CapitalBuy——Reiterated2025-05-13
—D. Boral CapitalBuy——Reiterated2025-03-31
—D. Boral CapitalBuy——Reiterated2025-03-28
—D. Boral CapitalBuy——Reiterated2025-03-26
—HC Wainwright & Co.Buy——Reiterated2025-03-12
—D. Boral CapitalBuy——Reiterated2025-03-07
—D. Boral CapitalBuy——Reiterated2025-02-27
—BenchmarkBuy——Reiterated2025-02-27
—D. Boral CapitalBuy——Reiterated2025-02-26
—D. Boral CapitalBuy——Reiterated2025-01-21

HUMA earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-03-27-0.13-0.13$1.3M$467K
2026-05-13-0.10-0.09$1.5M$495K
2026-08-12-0.11-0.16$1.0M$406K
2026-11-11-0.090.00$766K$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.